Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
Operating Expenses | 23,101 | 27,114 | 28,430 | 25,875 | 24,199 |
Operating Income | -23,101 | -27,114 | -28,430 | -25,875 | -24,199 |
Other Income | -20 | -45 | 12 | 47 | 20 |
Pre-tax Income | -23,121 | -27,159 | -28,418 | -25,828 | -24,179 |
Net Income Continuous | -23,121 | -27,159 | -28,418 | -25,828 | -24,179 |
Net Income | $-23,121 | $-27,159 | $-28,418 | $-25,828 | $-24,179 |
EPS Basic Total Ops | -0.88 | -1.04 | -1.09 | -0.99 | -1.00 |
EPS Basic Continuous Ops | -0.88 | -1.05 | -1.09 | -0.99 | -1.00 |
EPS Diluted Total Ops | -0.88 | -1.04 | -1.09 | -0.99 | -1.00 |
EPS Diluted Continuous Ops | -0.88 | -1.05 | -1.09 | -0.99 | -1.00 |
EBITDA(a) | $-21,900 | $-25,889 | $-27,208 | $-24,715 | $-23,109 |